842
Views
2
CrossRef citations to date
0
Altmetric
management of COPD, AATD and NCFBE: What can we learn from real-life data? - Introduction

Management of chronic airway diseases: What can we learn from real-life data?

 

Declaration of interest

James D. Chalmers currently holds research grants from Aradigm Corporation, AstraZeneca, Bayer Healthcare, Boehringer Ingelheim, European Union Innovative Medicines Initiative, GlaxoSmithKline, Insmed, Medical Research Council, Pfizer, Polyphor, Scottish Government, and Wellcome Trust. He has received fees for consultancy or speaking from AstraZeneca, Bayer Healthcare, Chiesi, Grifols, Napp, and Pfizer.

Editorial assistance was provided by Content Ed Net (Madrid, Spain) with funding from Grifols SA (Barcelona Spain).